Glucagon-like peptide-1 receptor agonists and sodium−glucose cotransporter 2 inhibitors for cardiovascular and renal protection: A treatment approach far beyond their glucose-lowering effect
Ricardo Gómez‐Huelgas, Jaime Sanz‐Cánovas, Lidia Cobos-Palacios, Almudena López‐Sampalo, Luis M. Pérez‐Belmonte
Topics & Concepts
MedicineDiabetes mellitusType 2 diabetesGlycemicRenal functionInternal medicineDiseaseHeart failureGlucagon-like peptide 1 receptorPharmacologyStroke (engine)EndocrinologyIntensive care medicineReceptorAgonistMechanical engineeringEngineeringDiabetes Treatment and ManagementPotassium and Related DisordersDiabetes Management and Research